Abstract:Background Most of hospitalized patents are at risk of developing deep vein thrombosis (DVT). The use of pharmacological prophylaxis significantly reduces the incidence of thromboembolic events in high risk patients. The aim of this study was to assess appropriateness of DVT prophylaxis in hospitalized medical patients in an Ethiopian referral hospital. Methods Cross-sectional study design was employed. Patients with a diagnosis of DVT, taking anticoagulant therapy, and those who refused to participate were ex… Show more
“…In line with other studies reported from Ethiopia, 23 , 24 in the present study, the most common risk factors for VTE were acute infection/and rheumatologic disorder (76.7%), reduced mobility (41.1%), having heart and /or respiratory failure (21.5%), elderly age ⩾70 years (13.7%), active cancer (10.5%), and acute myocardial infarction or ischemic stroke (12.8%).…”
Section: Discussionsupporting
confidence: 91%
“…Similarly, another study from Ethiopia reported that about 47.6% of medical inpatients had a significant DVT risk. 24 However, in our study, thromboprophylaxis was given to only 25.1% of patients and 6.84% of them received it without having risk or they were at lower risk which doesn’t mandate thromboprophylaxis and four patients were given pharmacologic prophylaxis despite the patients had absolute contraindication. There were 26 patients from high-risk group who did not get prophylaxis which may be due to ineligibility and/or contraindication, the fear of risk of bleeding and failure of prescribing them even for legible patients by prescribers.…”
Introduction: Venous thromboembolism is a major cause of mortality and morbidity among hospitalized patients and thromboprophylaxis is one of the key strategies to reduce such events. We aimed to assess venous thromboembolism risk using Padua prediction score, thromboprophylaxis practice, and outcomes in hospitalized medical patients at Tibebe Ghion Specialized Hospital, Bahir Dar, Ethiopia. Methods: A cross-sectional study was conducted among 219 patients admitted to Tibebe Ghion Specialized Hospital from 1 December 2018 to 31 May 2019. Data were collected from patients’ medical records using a pre-tested data abstraction format to collect patients’ clinical information and venous thromboembolism risk using the Padua prediction score. We used Statistical Package for the Social Sciences version 26 for data analysis. Descriptive statistics was used to summarize the findings, and binary logistic regression analysis was used to assess association between the variables of interest. Results: Reduced mobility, recent trauma and/or surgery, heart and/or respiratory failure, and active cancer were the frequently identified venous thromboembolism risk factors. Based on Padua prediction score, 48.4% of patients were at high risk of developing venous thromboembolism. The venous thromboembolism prophylaxis was given only for 55 (25.1%) patients and 15 of them were at low risk of developing venous thromboembolism (<4 Padua score) and were ineligible for thromboprophylaxis. Fifteen (6.84%) patients developed venous thromboembolism events during their stay at the hospital and 80% of them were from high risk group. The odds of females to develop venous thromboembolism were more than 14 times higher (adjusted odds ratio = 14.51; 95% confidence interval: 2.52–83.39, p = 0.003) than males. Reduced mobility (adjusted odds ratio = 10.00; 95% confidence interval: 1.70–58.70), <1 month trauma and/or surgery (adjusted odds ratio = 18.93; 95% confidence interval: 2.30–155.56), active cancer (adjusted odds ratio = 6.00; 95% confidence interval: 1.05–34.27), chronic kidney diseases (adjusted odds ratio = 61.790; 95% confidence interval: 2.627–1453.602), and hypertension (adjusted odds ratio = 7.270; 95% confidence interval: 1.105–47.835) were significantly associated with the risk of developing venous thromboembolism. Conclusion: Nearly half of the patients were at risk of developing venous thromboembolism. Underutilization of thromboprophylaxis and inappropriate use of prophylaxis were commonly seen in Tibebe Ghion Specialized Hospital.
“…In line with other studies reported from Ethiopia, 23 , 24 in the present study, the most common risk factors for VTE were acute infection/and rheumatologic disorder (76.7%), reduced mobility (41.1%), having heart and /or respiratory failure (21.5%), elderly age ⩾70 years (13.7%), active cancer (10.5%), and acute myocardial infarction or ischemic stroke (12.8%).…”
Section: Discussionsupporting
confidence: 91%
“…Similarly, another study from Ethiopia reported that about 47.6% of medical inpatients had a significant DVT risk. 24 However, in our study, thromboprophylaxis was given to only 25.1% of patients and 6.84% of them received it without having risk or they were at lower risk which doesn’t mandate thromboprophylaxis and four patients were given pharmacologic prophylaxis despite the patients had absolute contraindication. There were 26 patients from high-risk group who did not get prophylaxis which may be due to ineligibility and/or contraindication, the fear of risk of bleeding and failure of prescribing them even for legible patients by prescribers.…”
Introduction: Venous thromboembolism is a major cause of mortality and morbidity among hospitalized patients and thromboprophylaxis is one of the key strategies to reduce such events. We aimed to assess venous thromboembolism risk using Padua prediction score, thromboprophylaxis practice, and outcomes in hospitalized medical patients at Tibebe Ghion Specialized Hospital, Bahir Dar, Ethiopia. Methods: A cross-sectional study was conducted among 219 patients admitted to Tibebe Ghion Specialized Hospital from 1 December 2018 to 31 May 2019. Data were collected from patients’ medical records using a pre-tested data abstraction format to collect patients’ clinical information and venous thromboembolism risk using the Padua prediction score. We used Statistical Package for the Social Sciences version 26 for data analysis. Descriptive statistics was used to summarize the findings, and binary logistic regression analysis was used to assess association between the variables of interest. Results: Reduced mobility, recent trauma and/or surgery, heart and/or respiratory failure, and active cancer were the frequently identified venous thromboembolism risk factors. Based on Padua prediction score, 48.4% of patients were at high risk of developing venous thromboembolism. The venous thromboembolism prophylaxis was given only for 55 (25.1%) patients and 15 of them were at low risk of developing venous thromboembolism (<4 Padua score) and were ineligible for thromboprophylaxis. Fifteen (6.84%) patients developed venous thromboembolism events during their stay at the hospital and 80% of them were from high risk group. The odds of females to develop venous thromboembolism were more than 14 times higher (adjusted odds ratio = 14.51; 95% confidence interval: 2.52–83.39, p = 0.003) than males. Reduced mobility (adjusted odds ratio = 10.00; 95% confidence interval: 1.70–58.70), <1 month trauma and/or surgery (adjusted odds ratio = 18.93; 95% confidence interval: 2.30–155.56), active cancer (adjusted odds ratio = 6.00; 95% confidence interval: 1.05–34.27), chronic kidney diseases (adjusted odds ratio = 61.790; 95% confidence interval: 2.627–1453.602), and hypertension (adjusted odds ratio = 7.270; 95% confidence interval: 1.105–47.835) were significantly associated with the risk of developing venous thromboembolism. Conclusion: Nearly half of the patients were at risk of developing venous thromboembolism. Underutilization of thromboprophylaxis and inappropriate use of prophylaxis were commonly seen in Tibebe Ghion Specialized Hospital.
“…Deep venous thrombosis (DVT) can be prevented through non-pharmacologic prophylaxis (compression stockings, leg elevation, sequential compression devices (SCDs), ambulation, and vena cava filter) and pharmacologic intervention, which is through the use of blood-thinning medications[ 2 , 11 , 27 ]. The most common blood thinner prophylaxis in Ethiopia is unfractionated heparin (UFH) and warfarin.…”
Section: Discussionmentioning
confidence: 99%
“…The most common blood thinner prophylaxis in Ethiopia is unfractionated heparin (UFH) and warfarin. The major side effect of blood-thinning medications is an increased risk of bleeding and some patients are contraindicated for blood-thinning medications since they have a greater risk of developing adverse events[ 11 , 24 ]. The overall mortality rate in untreated patients is 30%, with approximately 10% of patients dying within 1 h of the event.…”
Section: Discussionmentioning
confidence: 99%
“…Pulmonary embolism is a potentially life-threatening condition that needs immediate diagnosis and management [ 9 ], since Surgery puts patients at a fivefold increased risk for pulmonary embolism[ [7] , [8] , [9] ], in addition, perioperative thromboprophylaxis is underutilization in Ethiopian hospital ward patients who have a risk of pulmonary embolism and professionals do not adhere to guideline recommendations[ 11 ].…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.